Bufferin ® Lidocaine Pain Numbing Cream

Manufacturer
Genomma Lab USA
Effective date
2023-08-21
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:27:04

Label at a glance#

ProductBufferin Lidocaine Pain Numbing
Active ingredientLidocaine hydrochloride
Label structure12 sections

Dosage and administration

use only as directed Adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daiIy Chidren under 12 years of age: ask a doctor

Storage and handling

store at 15 to 30"C (59 to 86"F) Tamper Evident: DO NOT USE IF SEAL ON TUBE IS PUNCTURED OR MISSING.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Lidocaine HCl 4%

Purpose

OTC - PURPOSE SECTION

Topical analgesics

Use

INDICATIONS & USAGE SECTION

For the temporarily relief of pain

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • in large quantities, particularly over raw surfaces or blistered areas
  • on wounds or damaged skin

When using this product

OTC - WHEN USING SECTION

  • use only as directed
  • avoid contact with eyes
  • do not apply tight bandages
  • do not apply a heating pad to treated skin

Stop use and ask a doctor If

OTC - STOP USE SECTION

  • condition worsens or symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children to avoid accidental ingestion

SPL UNCLASSIFIED SECTION

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use only as directed

SPL UNCLASSIFIED SECTION

Adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daiIy

SPL UNCLASSIFIED SECTION

Chidren under 12 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • store at 15 to 30"C (59 to 86"F)
  • Tamper Evident: DO NOT USE IF SEAL ON TUBE IS PUNCTURED OR MISSING.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Purified water, Aloe barbadensis leaf juice, Cetyl alcohol, Ethoxydiglycol, Stearic acid, Hemp seed oil, Sodium polyacrylate, Jojoba oil, Jeecide cap-5 (Phenoxyethanol, Caprylyl glycol, Potassium sorbate, Hexylene glycol), L-arginine, Benzophenone-4

Questions or comments?

OTC - QUESTIONS SECTION

Call toll free 1-877-994-3666

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY:
GENOMMA LAB USA, INC.,
HOUSTON, TX 77098

PRINCIPAL DISPLAY PANEL - 76.5 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

irwin
naturals®

BUFFERIN®

+
1000 mg
Hemp Seed Oil*
PER TUBE
CURATED FROM IRWIN NATURALS®

LIDOCAINE 4%
PAIN NUMBING CREAM

MAX STRENGTH†

BLOCKS PAIN RECEPTORS
HOURS OF RELIEF
*FOR SKIN CONDITIONING

NUMBS PAIN FAST
†WITHOUT A PRESCRIPTION

NET. WT 2.7 OZ (76.5 g)

PRINCIPAL DISPLAY PANEL - 76.5 g Tube Carton
PRINCIPAL DISPLAY PANEL - 76.5 g Tube Carton

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50066-61450066-614-27

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
29a0240b-77e8-4daf-ac9b-e318fc42bed867fac18d-62e4-4ae4-9c7f-a9427df32afb2025-01-29WarningsExact identifier
spl set id: 67fac18d-62e4-4ae4-9c7f-a9427df32afb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.